(Q33739402)

29 July 2017

Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults (English)

1 reference

29 July 2017

Shigella dysenteriae

1 reference

Rogerie F

1

1 reference

29 July 2017

Ott D

2

1 reference

29 July 2017

Vandepitte J

3

1 reference

29 July 2017

Verbist L

4

1 reference

29 July 2017

Lemmens P

5

1 reference

29 July 2017

Habiyaremye I

6

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 May 1986

1 reference

Antimicrobial Agents and Chemotherapy

29 July 2017

1 reference

29 July 2017

29

1 reference

29 July 2017

5

1 reference

29 July 2017

883-886

1 reference

Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284172

A bacillary dysentery epidemic in Dar es Salaam, Tanzania

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284172

Drug resistance in Shigella dysenteriae, S flexneri and S boydii in England and Wales: increasing incidence of resistance to trimethoprim

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284172

Epidemic Shiga bacillus dysentery in Central Africa

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284172

In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284172

Resistant Shigella dysenteriae.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284172

Acquisition of trimethoprim resistance in epidemic strain of Shigella dysenteriae type 1 from Zaire

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284172

Plasmid characterisation in the investigation of an epidemic caused by multiply resistant Shigella dysenteriae type 1 in Central Africa

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284172

Treatment of sonne dysentery

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284172

Comparative efficacy of nalidixic acid and ampicillin for severe shigellosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284172

Shigella and Salmonella species from Kigali (Rwanda) (1976-1982).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284172

Plasmid characterization of drug-resistant Shigella dysenteriae 1 from an epidemic in Central Africa

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284172

Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284172

Multiresistant Shigella infections in Bangladesh.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284172

Outbreak of Shigella dysentery in Eastern Zaire, 1980-1982

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284172

The comparative activity of norfloxacin with other antimicrobial agents against Gram-positive and Gram-negative bacteria.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284172

Nalidixic acid for shigellosis

30 October 2018

1 reference

12 December 2020

Multiple transmissible drug resistance in an outbreak of Shigella flexneri infection

1 reference

12 December 2020

Controlled comparison of nalidixic acid or lactulose with placebo in shigellosis

1 reference

12 December 2020

Nalidixic acid in Shigella dysenteriae outbreaks

1 reference

12 December 2020

Nalidixic acid analogues and Shigella

1 reference

12 December 2020

Epidemic of dysentery in West Bengal: clinicians' enigma

1 reference

12 December 2020

Nalidixic-acid-resistant Shigella dysenteriae I

1 reference

12 December 2020

Nalidixic acid for shigellosis

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.29.5.883

1 reference

29 July 2017

1 reference

29 July 2017

1 reference